JOHNSON & JOHNSON
SC 14D1/A, 1998-09-16
PHARMACEUTICAL PREPARATIONS
Previous: SALOMON SMITH BARNEY HOLDINGS INC, 424B2, 1998-09-16
Next: AMRESCO INC, S-3, 1998-09-16





===========================================================================




                     SECURITIES AND EXCHANGE COMMISSION
                           WASHINGTON, D.C. 20549

                              AMENDMENT NO. 4
                                     to
                               SCHEDULE 14D-1
                           Tender Offer Statement
    Pursuant to Section 14(d)(1) of the Securities Exchange Act of 1934

                                    and

                              AMENDMENT NO. 5
                                     to
                                SCHEDULE 13D
                 Under the Securities Exchange Act of 1934

                                DEPUY, INC.
                         (Name of Subject Company)

                           LIB ACQUISITION CORP.
                             JOHNSON & JOHNSON
                                 (Bidders)

                   Common Stock, Par Value $.01 Per Share
                       (Title of Class of Securities)

                                249726 10 0
                   (CUSIP Number of Class of Securities)

                           James R. Hilton, Esq.
                           LIB Acquisition Corp.
                           c/o Johnson & Johnson
                        One Johnson & Johnson Plaza
                      New Brunswick, New Jersey 08933
                               (732) 524-2450
          (Name, Address and Telephone Number of Person Authorized
      to Receive Notices and Communications on Behalf of the Bidders)

                                 Copies to:
                          Robert A. Kindler, Esq.
                          Cravath, Swaine & Moore
                              Worldwide Plaza
                             825 Eighth Avenue
                          New York, New York 10019
                               (212) 474-1000

                             September 15, 1998
      (Date of Event Which Requires Filing Statement on Schedule 13D)


===========================================================================


<PAGE>


          This statement amends and supplements the combined Tender Offer
Statement on Schedule 14D-1, as amended by Amendment Nos. 1 through 3
thereto, and Statement on Schedule 13D, as amended by Amendment Nos. 1
through 4 thereto, originally filed with the Securities and Exchange
Commission on July 27, 1998 (collectively and as amended, the "Schedule
14D-1 & Schedule 13D"), by Johnson & Johnson, a New Jersey corporation
("Parent"), and LIB Acquisition Corp., a Delaware corporation and a wholly
owned subsidiary of Parent (the "Purchaser"), in connection with the offer
to purchase all the outstanding shares of Common Stock, par value $.01 per
share (the "Shares"), of DePuy, Inc., a Delaware corporation (the
"Company"), at $35 per Share, net to the seller in cash, without interest,
upon the terms and subject to the conditions set forth in the Offer to
Purchase dated July 27, 1998 (the "Offer to Purchase"), and in the related
Letter of Transmittal (which, together with any amendments or supplements
thereto, collectively constitute the "Offer"). Capitalized terms used and
not defined herein shall have the meanings assigned to such terms in the
Offer to Purchase and the Schedule 14D-1 & Schedule 13D.

Item 10.  Additional Information.

          Items 10(b) and 10(c) of the Schedule 14D-1 & Schedule 13D are
hereby amended and supplemented by adding the following language thereto:

          On September 15, 1998, Parent issued a press release, a copy of
     which is attached hereto as Exhibit (a)(11) and is incorporated herein
     by reference.

Item 11.  Material to be Filed as Exhibits.

          Item 11 is hereby amended and supplemented by adding the
following:

     (a)(11) Text of Press Release dated September 15, 1998, issued by
             Parent.



                                     2

<PAGE>



                                 SIGNATURE

          After due inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

Dated: September 16, 1998


                                   LIB ACQUISITION CORP.


                                   By: /s/ Peter S. Galloway
                                       -------------------------
                                       Name:  Peter S. Galloway
                                       Title: Vice President


                                   JOHNSON & JOHNSON


                                   By: /s/ Peter S. Galloway
                                       -------------------------
                                       Name:  Peter S. Galloway
                                       Title: Secretary


                              3

<PAGE>


                               EXHIBIT INDEX


Exhibit        
Number         Exhibit Name                                     Page No.

*(a)(1)       Offer to Purchase.
*(a)(2)       Letter of Transmittal.
*(a)(3)       Notice Of Guaranteed Delivery.
*(a)(4)       Letter to Brokers, Dealers, Commercial
              Banks, Trust Companies and Other Nominees.
*(a)(5)       Letter to Clients for use by Brokers,
              Dealers, Commercial Banks, Trust Companies
              and Other Nominees.
*(a)(6)       Guidelines for Certification of Taxpayer
              Identification Number on Substitute Form
              W-9.
*(a)(7)       Form of Summary Advertisement dated July 27,
              1998.
*(a)(8)       Text of Joint Press Release dated July 21,
              1998, issued by the Company, Parent and
              Roche Holding Ltd.
*(a)(9)       Text of Press Release dated August 4, 1998,
              issued by Parent.
*(a)(10)      Text of Press Release dated August 20, 1998,
              issued by Parent.
 (a)(11)      Text of Press Release dated September 15,
              1998, issued by Parent.
 (b)          None.
*(c)(1)       Agreement and Plan of Merger dated as of
              July 21, 1998,  among  Parent,  the  Purchaser  and the
              Company.
*(c)(2)       Stockholder  Agreement dated as of July 21, 1998, among
              Parent,  the Purchaser and certain  stockholders of the
              Company.
(d)           None.
(e)           Not applicable.
(f)           None.
- --------------------
*Previously filed.


                                     4

<PAGE>


                                              EXHIBIT (a)(11)

                                            Johnson & Johnson
                                      NEW BRUNSWICK, NJ 08933

Contact:  Robert V. Andrews - Media Relations
          (732) 524-3348

          David R. Sheffield - Investor Relations
          (732) 524-6491

                                      [FOR IMMEDIATE RELEASE]

                 Johnson & Johnson Announces
               European Union Antitrust Filing
                And Extension of Tender Offer
                for DePuy, Inc. to October 16

          New Brunswick, NJ (Sept. 15, 1998) - Johnson &
Johnson (NYSE: JNJ) announced that today it filed the
required notification with the Commission of the European
Union with respect to its tender offer for all outstanding
shares of common stock of DePuy, Inc. (NYSE: DPU).

          The Commission will have one month to complete its
preliminary investigation and determine whether it needs to
initiate a further investigation of the transaction. Because
clearance under the European Union merger control regulation
accordingly will not be obtained prior to the currently
scheduled October 5 expiration date for the tender offer,
Johnson & Johnson and DePuy have agreed that the tender offer
will be extended until 5:00 P.M., New York City time, on
October 16, 1998.

          The depositary for the tender offer, First Chicago
Trust Company of New York, has advised Johnson & Johnson that
93,040,007 DePuy shares, approximately 92.2% of the
outstanding shares on a fully diluted basis, had been
tendered and not withdrawn as of the close of business on
Monday, September 14, 1998.

                            # # #


                              5


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission